| Primary |
| Drug Use For Unknown Indication |
38.8% |
| Premedication |
29.1% |
| Chemotherapy |
5.8% |
| Ascites |
1.9% |
| Aspergillosis |
1.9% |
| Breast Cancer Metastatic |
1.9% |
| Chronic Graft Versus Host Disease In Skin |
1.9% |
| Colon Cancer Metastatic |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Lung Infection |
1.9% |
| Mycobacterium Marinum Infection |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Urinary Tract Infection |
1.9% |
| Anaemia |
1.0% |
| Antibiotic Therapy |
1.0% |
| Antiviral Prophylaxis |
1.0% |
| Anxiety |
1.0% |
| Basedow's Disease |
1.0% |
| Breast Cancer |
1.0% |
| Cardiac Failure |
1.0% |
|
| Vision Blurred |
9.7% |
| Vomiting |
9.7% |
| Anaemia Haemolytic Autoimmune |
6.5% |
| Gestational Diabetes |
6.5% |
| Hypertrichosis |
6.5% |
| Pyrexia |
6.5% |
| Skin Exfoliation |
6.5% |
| Thrombocytopenia |
6.5% |
| Vertigo |
6.5% |
| Cardiogenic Shock |
3.2% |
| Depressed Level Of Consciousness |
3.2% |
| Drug Exposure During Pregnancy |
3.2% |
| Hypovolaemia |
3.2% |
| Limb Malformation |
3.2% |
| Loss Of Consciousness |
3.2% |
| Melanosis Coli |
3.2% |
| Pallor |
3.2% |
| Pancytopenia |
3.2% |
| Pemphigoid |
3.2% |
| Pruritus |
3.2% |
|
| Secondary |
| Premedication |
24.7% |
| Anaesthesia |
17.9% |
| Product Used For Unknown Indication |
15.3% |
| Pain |
7.2% |
| Breast Cancer |
6.8% |
| Drug Use For Unknown Indication |
4.3% |
| Aspergillosis |
2.6% |
| Breast Cancer Metastatic |
2.6% |
| Lung Infection |
2.6% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Chemotherapy |
1.7% |
| Chronic Graft Versus Host Disease In Skin |
1.7% |
| Ovarian Cancer |
1.7% |
| Anaemia |
1.3% |
| Antiviral Prophylaxis |
1.3% |
| Anxiety |
1.3% |
| Crohn's Disease |
1.3% |
| Epilepsy |
1.3% |
| Hepatitis C |
1.3% |
| Nausea |
1.3% |
|
| Hepatocellular Injury |
12.8% |
| Vomiting |
12.8% |
| Hepatitis |
10.6% |
| Acute Generalised Exanthematous Pustulosis |
6.4% |
| Loss Of Consciousness |
6.4% |
| Rash Erythematous |
6.4% |
| Thrombocytopenia |
6.4% |
| Thrombotic Microangiopathy |
6.4% |
| Jaundice |
4.3% |
| Limb Malformation |
4.3% |
| Myocardial Infarction |
4.3% |
| Dermatitis Exfoliative |
2.1% |
| Dyspnoea |
2.1% |
| Electrocardiogram Abnormal |
2.1% |
| Erythema |
2.1% |
| Hirsutism |
2.1% |
| Hypertrichosis |
2.1% |
| Hypovolaemia |
2.1% |
| Hypoxia |
2.1% |
| Malaise |
2.1% |
|
| Concomitant |
| Premedication |
13.7% |
| Drug Use For Unknown Indication |
11.8% |
| Ovarian Cancer |
9.8% |
| Parenteral Nutrition |
9.8% |
| Coronary Artery Disease |
6.5% |
| General Anaesthesia |
6.5% |
| Renal Transplant |
6.5% |
| Breast Cancer |
5.2% |
| Product Used For Unknown Indication |
3.9% |
| Hypertension |
3.3% |
| Acute Coronary Syndrome |
2.6% |
| Asthma |
2.6% |
| Glaucoma |
2.6% |
| Hodgkin's Disease |
2.6% |
| Vocal Cord Neoplasm |
2.6% |
| Adrenal Insufficiency |
2.0% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Ear Infection |
2.0% |
| Heart Transplant |
2.0% |
| Hepatitis C |
2.0% |
|
| Pruritus |
9.3% |
| Pyrexia |
9.3% |
| Nausea |
7.0% |
| Pancreatitis |
7.0% |
| Peripheral Sensorimotor Neuropathy |
7.0% |
| Shock |
7.0% |
| Urticaria |
7.0% |
| Leukopenia |
4.7% |
| Lipase Increased |
4.7% |
| Lymphocele |
4.7% |
| Proteinuria |
4.7% |
| Somnolence |
4.7% |
| Tubulointerstitial Nephritis |
4.7% |
| Vomiting |
4.7% |
| Circulatory Collapse |
2.3% |
| Complex Regional Pain Syndrome |
2.3% |
| Cystitis Haemorrhagic |
2.3% |
| Electrocardiogram St Segment Elevation |
2.3% |
| Generalised Erythema |
2.3% |
| Hepatic Lesion |
2.3% |
|
